A small study found MS patients reported improved quality of life and reduced depression after Ocrelizumab biosimilar ...

A brief, four-session stress management program helped ease symptoms of depression and anxiety and reduced stress in people ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

Achieving 100 enrolled patients in the NIH‑funded SEANOBI Expanded‑Access Program marks substantial progress in the clinical development of MN‑166. We are deeply grateful to the patients and families ...

VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

MS is an autoimmune disorder in which the immune system attacks myelin, the protective covering of nerve fibres in the brain ...

Maimonides Health marked a new chapter in women’s health care on Jan. 28 with the grand opening of its Women’s Neurology ...

Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...

Mehki Brooks, 20, took care of his ailing mother and had multiple promising career prospects. But on Dec. 30, Brooks died ...

AB Science receives Japanese patent for use of masitinib in progressive forms of multiple sclerosis: Paris Friday, January 23, 2026, 14:00 Hrs [IST] AB Science SA, a pharmaceutica ...

Melinda Lou Simmons, age 77, of Atascadero, passed away on December 29, 2025, in San Luis Obispo due to complications from ...

Known as the Kent MS Therapy Centre for 41 years, its name has been changed to the Kent Neuro Therapy Centre. The expanded service will provide therapy for people with MS, Parkinson's disease and ...